The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

May. 05, 2014
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Paolo Fiorina, Boston, MA (US);

Andrea Vergani, Brookline, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 31/436 (2006.01); A61K 31/7076 (2006.01); A61K 45/06 (2006.01); A61K 31/166 (2006.01); A61K 31/402 (2006.01); A61K 31/53 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 47/48369 (2013.01); A61K 31/166 (2013.01); A61K 31/402 (2013.01); A61K 31/436 (2013.01); A61K 31/53 (2013.01); A61K 31/7076 (2013.01); A61K 45/06 (2013.01); A61K 47/68 (2017.08);
Abstract

The present invention relates to the role of purinergic receptors and ATP in T cell activation and autocrine system signaling. In one embodiment, the present invention provides a method of preventing or treating diabetes by administering a therapeutically effective inhibitor of ATP to a subject. In another embodiment, the present invention provides a method of preventing or treating fibrosis by administering a P2X7R soluble fusion protein. In another embodiment, the present invention provides a method of preventing or treating graft rejection by administering an inhibitor of P2X receptor signaling.


Find Patent Forward Citations

Loading…